Search
Close this search box.

Company Name: KalVista Pharmaceuticals, Inc.

Company Name: KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. is a pharmaceutical company.  The company is engaged in the development of small molecule protease inhibitors.  The company’s pipeline includes product candidates designed to treat hereditary angioedema (HAE) and diabetic macular edema (DME).

Ticker Symbol: KALV (NASDAQ)

Company Website: http://www.kalvista.com

Headquarters: Cambridge, MA